X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38) 38
oncology (37) 37
humans (36) 36
female (26) 26
male (26) 26
middle aged (26) 26
aged (25) 25
adult (18) 18
chemotherapy (18) 18
aged, 80 and over (15) 15
cancer (15) 15
analysis (14) 14
treatment outcome (13) 13
prognosis (10) 10
tumors (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
care and treatment (9) 9
disease-free survival (8) 8
medical research (8) 8
neoplasm staging (8) 8
research (8) 8
lung neoplasms - pathology (7) 7
carcinoma, non-small-cell lung - drug therapy (6) 6
carcinoma, non-small-cell lung - pathology (6) 6
hematology (6) 6
hematology, oncology and palliative medicine (6) 6
prospective studies (6) 6
radiotherapy (6) 6
retrospective studies (6) 6
survival (6) 6
switzerland (6) 6
young adult (6) 6
antineoplastic agents - therapeutic use (5) 5
breast cancer (5) 5
clinical trials (5) 5
disease progression (5) 5
lung cancer, non-small cell (5) 5
lung neoplasms - drug therapy (5) 5
mutation (5) 5
quality of life (5) 5
research article (5) 5
studies (5) 5
therapy (5) 5
610 medicine & health (4) 4
adolescent (4) 4
biomarkers, tumor - genetics (4) 4
breast-cancer (4) 4
cancer therapies (4) 4
carcinoma, non-small-cell lung - mortality (4) 4
colon cancer (4) 4
colonic neoplasms - pathology (4) 4
colorectal cancer (4) 4
docetaxel (4) 4
drug administration schedule (4) 4
gene (4) 4
health care sciences & services (4) 4
immunohistochemistry (4) 4
impact (4) 4
kaplan-meier estimate (4) 4
lung cancer (4) 4
lung neoplasms - mortality (4) 4
medicine (4) 4
medicine & public health (4) 4
metastasis (4) 4
neoplasms - therapy (4) 4
non-small cell lung cancer (4) 4
oncology, experimental (4) 4
quality (4) 4
respiratory system (4) 4
survival analysis (4) 4
adenocarcinoma (3) 3
adjuvant treatment (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biomarkers, tumor - metabolism (3) 3
cancer patients (3) 3
cancer research (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
cetuximab (3) 3
clinical-trials (3) 3
development and progression (3) 3
efficacy (3) 3
erlotinib (3) 3
gefitinib (3) 3
gene expression (3) 3
gene expression profiling (3) 3
genetic aspects (3) 3
lung neoplasms - genetics (3) 3
metastatic colorectal-cancer (3) 3
microsatellite instability (3) 3
molecular biology (3) 3
multicenter (3) 3
open-label (3) 3
palliative care (3) 3
patients (3) 3
phase-iii (3) 3
predictive value of tests (3) 3
proliferation (3) 3
prostate cancer (3) 3
radiation-therapy (3) 3
randomized-trial (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 03/2017, Volume 10, Issue 1, pp. 70 - 10
Background/purpose: Recently, the mutational background of diffuse large B cell lymphoma (DLBCL) has been revealed, identifying specific genetic events that... 
Prognostic markers | CREBBP | DLBCL | SOCS1 | Targeted high-throughput sequencing | EP300 | NGS | Lymphoma | RITUXIMAB-CHOP | R-CHOP | DLBCL PATIENTS | GENOME | CHEMOTHERAPY | CONSORTIUM | BIOMARKERS | INTEGRATION | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | HEMATOLOGY | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Humans | Middle Aged | E1A-Associated p300 Protein - genetics | Male | Cyclophosphamide - therapeutic use | CREB-Binding Protein - genetics | Young Adult | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Suppressor of Cytokine Signaling 1 Protein - genetics | Survival Rate | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Vincristine - therapeutic use | Aged | Mutation | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Exons | Leukemia | Clinical trials | Rituximab | Prednisone | Kinases | Gene expression | Survival | Vincristine | Proteins | Studies | Cyclophosphamide | Algorithms | Lymphocytes B | Medical prognosis | Classification | Remission | Lymphomas | Evolution & development | Deoxyribonucleic acid--DNA | DNA sequencing | Tumors | B-cell lymphoma
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0123435
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 12/2018, Volume 67, Issue 12, pp. 1825 - 1832
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 09/2019, Volume 9, Issue 1, pp. 1 - 11
The assessment of Ki-67 in early-stage breast cancer has become an important diagnostic tool in planning adjuvant therapy, particularly for the administration... 
INTERNATIONAL EXPERT CONSENSUS | VARIABILITY | PRIMARY THERAPY | MULTIDISCIPLINARY SCIENCES | VISUAL ASSESSMENT | IMAGE-ANALYSIS | LABELING INDEX | KI67 EXPRESSION | PREDICTIVE-VALUE | PROLIFERATION | HIGHLIGHTS | Immunohistochemistry | Confidence intervals | Chemotherapy | Menopause | Clinical trials | Estrogen receptors | Breast cancer | mRNA | Paraffin | Cancer therapies | Tumors
Journal Article
Haematologica, ISSN 0390-6078, 07/2012, Volume 97, Issue 7, pp. 1085 - 1091
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2012, Volume 104, Issue 21, pp. 1635 - 1646
Journal Article
BMC CANCER, ISSN 1471-2407, 09/2019, Volume 19, Issue 1, pp. 902 - 7
BackgroundThe impact of HER2-targeted therapy alone followed by the addition of chemotherapy at disease progression (PD) versus upfront combination was... 
ONCOLOGY | Trastuzumab monotherapy | Long-term responders | HER-positive breast cancer | THERAPIES | DOCETAXEL | CHEMOTHERAPY | PROGRESSION | Treatment outcome | Usage | Analysis | Development and progression | Breast cancer | Genetic aspects | Drug therapy | Multivariate analysis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2015, Volume 33, Issue 23, pp. 2523 - 2529
Journal Article
16.